Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.

Liu Z, Hamamichi S, Lee BD, Yang D, Ray A, Caldwell GA, Caldwell KA, Dawson TM, Smith WW, Dawson VL.

Hum Mol Genet. 2011 Oct 15;20(20):3933-42. doi: 10.1093/hmg/ddr312. Epub 2011 Jul 18.

PMID:
21768216
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.

Di Domenico F, Sultana R, Ferree A, Smith K, Barone E, Perluigi M, Coccia R, Pierce W, Cai J, Mancuso C, Squillace R, Wiengele M, Dalle-Donne I, Wolozin B, Butterfield DA.

Antioxid Redox Signal. 2012 Dec 1;17(11):1490-506. Epub 2012 Mar 20.

PMID:
22315971
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in caenorhabditis elegans models of manganism and parkinson disease.

Settivari R, Levora J, Nass R.

J Biol Chem. 2009 Dec 18;284(51):35758-68. doi: 10.1074/jbc.M109.051409. Epub .

PMID:
19801673
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans.

Kuwahara T, Koyama A, Gengyo-Ando K, Masuda M, Kowa H, Tsunoda M, Mitani S, Iwatsubo T.

J Biol Chem. 2006 Jan 6;281(1):334-40. Epub 2005 Oct 31.

PMID:
16260788
[PubMed - indexed for MEDLINE]
Free Article
5.

C. elegans as a model system for Parkinson disease.

Pu P, LE WD.

Neurosci Bull. 2006 Mar;22(2):124-8.

PMID:
17687410
[PubMed]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk